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Purpose: Nanotechnologies turned out to be promising in the development of diagnostic and 
therapeutic approaches toward neurodegenerative disorders. However, only a very scant number 
of nanodevices until now proved to be effective on preclinical animal models. Although specific 
tests in vivo are available to assess the potential toxicity of these nanodevices on cognitive func-
tions, those to evaluate their biosafety in vitro on neurons are still to be improved.
Materials and methods: We utilized the patch-clamp technique on primary cultures of cortical 
neural cells isolated from neonatal rats, aiming to evaluate their electrical properties after the 
incubation with liposomes (mApoE-PA-LIPs), previously proved able to cross the blood–brain 
barrier and to be effective on mouse models of Alzheimer’s disease (AD), both in the absence 
and in the presence of β-amyloid peptide oligomers.
Results: Data show a high degree of biocompatibility, evaluated by lactate dehydrogenase 
(LDH) release and MTT assay, and the lack of cellular internalization. After the incubation 
with mApoE-PA-LIPs, neuronal membranes show an increase in the input resistance (from 
724.14±76 MΩ in untreated population to 886.06±86 MΩ in the treated one), a reduction in 
the rheobase current (from 29.6±3 to 24.2±3 pA in untreated and treated, respectively), and an 
increase of the firing frequency, consistent with an ultimate increase in intrinsic excitability. 
Data obtained after co-incubation of mApoE-PA-LIPs with β-amyloid peptide oligomers sug-
gest a retention of liposome efficacy.
Conclusion: These data suggest the ability of liposomes to modulate neuronal electrical prop-
erties and are compatible with the previously demonstrated amelioration of cognitive functions 
induced by treatment of AD mice with liposomes. We conclude that this electrophysiological 
approach could represent a useful tool for nanomedicine to evaluate the effect of nanoparticles 
on intrinsic neuronal excitability.
Keywords: neurodegenerative disorders, nanomedicine, action potential, electrophysiology, 
patch clamp, β-amyloid peptide
Introduction
Alzheimer’s disease (AD) is one of the most studied and worldwide common neurode-
generative disorders. As such, AD has the clinical feature of a selective and progressive 
loss of neuronal cells, which is responsible for the typical behavioral and physical 
deficits. There are many different pathological events happening in the brain, such as 
accumulation of the β-amyloid peptide (Aβ), presence of neurofibrillary tangles of 
the microtubule-associated hyper-phosphorylated protein tau, neuronal and synaptic 
loss, cerebral atrophy, and signs of inflammation. Among these events, researchers 
suggest that the generation of the neurotoxic Aβ peptide from sequential amyloid 
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precursor protein (APP) proteolysis is the crucial step in the 
development of AD.
So far, current different therapeutic strategies for AD 
offer modest and short-term benefits. Nanotechnologies, 
which consist in the research of tools and systems through the 
nanometric control of the material,1 are very promising in the 
development of both diagnostic and therapeutic approaches 
for neurodegenerative diseases.
Among the reasons, nanocarriers could be functionalized 
in order to have the ability to cross the blood–brain barrier 
(BBB), improving both qualitatively and quantitatively the 
transport of drugs directed to the central nervous system 
(CNS), and limiting, at the same time, side effects. In recent 
years, our group developed multifunctional nanoliposomes, 
composed of sphingomyelin (Sm) and cholesterol (Chol) 
and bifunctionalized with phosphatidic acid (PA) and with 
a peptide (mApoE) derived from the receptor-binding 
domain of apolipoprotein E (named mApoE-PA-LIPs) as 
a candidate for the treatment of AD.2–4 The presence of PA 
has been shown to confer to LIPs strong affinity for Aβ in 
different aggregation forms; mApoE-derived molecules, 
instead, improve the passage of nanoliposomes across the 
BBB either in vitro or in vivo.5
In vivo studies on mouse model of AD demonstrated that 
mApoE-PA-LIPs cross the BBB and showed the efficacy to 
recover long-term recognition memory and to reduce the 
number and total area of Aβ plaques in the brain.6 These same 
nanoliposomes have been confirmed to prevent memory loss 
in a presymptomatic mouse model of AD as well.7
The mechanism of action responsible for these improve-
ments could be inferred by the results obtained in vitro: mApoE-
PA-LIPs were able to bind to Aβ with high affinity, to inhibit 
the formation, and to destabilize the preformed accumulation 
of Aβ
1–42
 aggregates without affecting either endothelial and 
neuroblastoma cells’ viability or the BBB monolayer integrity. 
Moreover, they were internalized by cells, likely by a receptor-
mediated endocytosis and transported in their intact form across 
the monolayer of hCMEC/D3, a model of BBB.3
Eventually, mApoE-PA-LIPs possess the capacity to 
sequester Aβ
1–42
 in human plasma and cerebrospinal fluid4 
endorsing the hypothesis of the “sink effect” supported by the 
in vivo data related to the increment of Aβ in the liver and in 
the spleen in AD mice treated with mApoE-PA-LIPs.6
However, nanoparticles (NPs) used as therapeutic tool 
cannot be considered as an inert delivery vehicle.8 Even 
though liposomes (LIPs) are considered to be more bio-
compatible with respect to other NPs, it has been reported 
that amine-modified polystyrene NPs or gold NPs change 
the membrane cellular potential in non-excitable cells 
upon binding, not by acting as permeabilizing agent, but 
by interfering with potassium channels responsible for the 
maintenance of the resting potential.9 In plant cells, silver 
NPs were responsible for an increase of intracellular calcium 
concentration that was prevented by the application of Gd3+, a 
calcium channel blocker; moreover, they inhibited potassium 
outward current as well.10
Since mApoE-PA-LIPs have been developed as a thera-
peutic tool for AD and are able to cross the BBB, attention 
has to be payed to their possible adverse effects. The in vivo 
data obtained on transgenic mice exposed to mApoE-PA-LIPs 
suggest that no apparent acute toxicity effect is exerted on 
the brain, at least under the experimental conditions adopted. 
Nevertheless, neurons are likely the most delicate cells of the 
body; thus, the possible effects on the physiological activity of 
excitable cells of the CNS have to be still thoroughly investi-
gated. Indeed, the environment beyond the barrier is rich in 
neurons, whose electrophysiological properties should be pre-
served in order to maintain their electrical activity. Therefore, 
in this study, we evaluated the effects of mApoE-PA-LIPs on 
the excitable properties of primary culture of cortical neurons 
isolated from neonatal rats. Moreover, due to the difficulties 
of obtaining single neuronal cells from adult mice model of 
AD, we mimicked the in vivo condition incubating cortical 
neurons with Aβ oligomers and investigated whether mApoE-
PA-LIPs retained the ability to exert their effect.
Materials and methods
Primary cell culture
All procedures involving animals and their care were con-
ducted according to European and Italian laws and policies 
(D. Lgs. no 2014/26, 2010/63/UE) and approved by the 
University of Bicocca Animal Care and Use Committee that 
includes ad hoc members for ethical issues. Primary cultures of 
cortical neural cells were isolated from neonatal rats (Charles 
River), 3 days postbirth (P3),11 and cultured for 6 or 7 days 
(DIV6–7) in p35 dishes coated with poly-l-lysine in a con-
trolled environment (5% CO
2
, 37°C) in Neurobasal A culture 
medium (Thermo Fisher Scientific, Waltham, MA, USA) 
supplemented with B27 (Thermo Fisher Scientific), glutamine 
(1 mM; Thermo Fisher Scientific), β-FGF (10 ng/mL; Thermo 
Fisher Scientific), penicillin G (50 U/mL) and streptomycin 
(50 µg/mL; Thermo Fisher Scientific). The culture contained 
both neurons and non-neuronal cells, such as astrocytes as the 
experiments of immunofluorescence proved.
The authors confirm that all the mandatory health and 
safety procedures have been complied with in the course 
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of conducting any experimental work reported in the pres-
ent paper.
Preparation and characterization of 
multifunctional lIPs
LIPs, designed for Alzheimer’s treatment, were prepared 
and characterized as previously described.12,13 Briefly, LIPs 
were composed of a matrix of Sm and Chol (1:1 molar ratio), 
prepared by extrusion procedure and functionalized with PA, 
as Aβ-binding agent, and with a modified peptide (mApoE) 
derived from the receptor-binding domain of apolipoprotein E, 
as BBB target ligand. These multifunctional LIPs are dubbed 
as mApoE-PA-LIPs.
For immunofluorescence experiments, fluorescent mApoE-
PA-LIPs, carrying BODIPY-FL C12-Sm (Thermo Fisher 
Scientific) in the lipid bilayer, were used. The fluorescent 
probe (0.5% mol of total lipids) was added to the lipid mixture 
before the extrusion procedure. To remove un-incorporated 
material, LIPs were diafiltered through 30,000 molecular 
weight (MW) cutoff membrane, as described.6 The yield of 
fluorescent probe incorporation and surface functionalization 
with mApoE peptide was determined by spectrofluorometric 
analysis. The total lipid recovery was measured by Stewart’s 
assay. Size and polydispersity index (PDI) were analyzed by 
dynamic light scattering (DLS) technique (Brookhaven Instru-
ments Corporation, NY, USA). ζ-potential was determined by 
using an interferometic Doppler velocimetry with the same 
instrument equipped with ZetaPALS device.
Preparation of aβ oligomers
Aβ oligomers were prepared as previously described.3,14 
Briefly, Aβ
1–42
 (Sigma-Aldrich Co., St Louis, MO, USA) 
lyophilized peptide was solubilized in 1,1,3,3,3-hexafluoro- 
2-propanol (HFIP, Sigma-Aldrich Co) at 1 mg/mL concentra-
tion. The peptide was allowed to air dry in a chemical fume 
hood overnight and suspended in dimethyl sulfoxide (DMSO; 
Sigma-Aldrich Co) in order to obtain a peptide concentration 
of 5 mM. After bath sonication of 10 min, the sample was 
diluted to 100 µM in phosphate-buffered solution (PBS) 
and incubated 24 h at 4°C to obtain an oligomer-enriched 
preparation. The formation of oligomers was assessed by 
atomic force microscopy as described.3,14
effect of treatment with multifunctional 
lIPs on cell viability
Cortical neural cells were plated on 96 wells at a density of 
5,000 cells/well and kept in a controlled environment (37°C 
and 5% CO
2
). At DIV6, cells were exposed for 4 or 48 h to 
the medium containing mApoE-PA-LIPs at a concentration 
of 10 µM. This dose was chosen based on in vivo studies as 
the concentration of NPs able to reach the brain.3,6 The effect 
of treatment with LIPs on cells’ viability was assessed by 
measuring the lactate dehydrogenase (LDH) release (LDH 
Cytotoxicity Detection KitPLUS; Hoffman-La Roche Ltd., 
Basel, Switzerland) and by measuring the mitochondrial 
enzymatic activity by MTT assay (MTT Formazan; Sigma-
Aldrich Co.), as previously described.15 Untreated cells were 
used as negative control. For the LDH assay, cells lysed with 
a specific buffer in order to free the whole cellular LDH 
were used as positive control, whereas for the MTT assay, 
the positive control is not required.
cellular uptake of lIPs by 
immunofluorescence
Cells were seeded on glass coverslips. At the end of 
incubation (1, 4 or 24 h) with 10 µM of fluorescent 
labeled mApoE-PA-LIPs, neural cultures were fixed 
with paraformaldehyde (PFA), washed three times with 
protein-free PBS and incubated with anti-βIII Tubulin 
antibody (1:250; Promega Corporation, Fitchburg, WI, 
USA) or with glial fibrillary acidic protein (GFAP) antibody 
(1:400; Sigma-Aldrich Co) for 2 h at room temperature 
and, after washes, with Alexa Fluor 594-conjugated goat 
anti-mouse IgG (1:100; Thermo Fisher Scientific) for 1 h 
at room temperature. 1 µM DAPI (Sigma-Aldrich Co) was 
used to label nuclei. Images were acquired with LSM710 
inverted confocal laser scanning microscope equipped with 
a Plan-Neofluar 63×1.4 oil objective (Carl Zeis Meditec AG, 
Jena, Germany). Excitation wavelengths were λ=488 nm 
to detect LIPs, λ=610 nm to detect βIII Tubulin or GFAP, 
and λ=405 nm to detect nuclei.
LIPs–cells interaction by fluorescence 
imaging of live cells
Cells were seeded on glass coverslips. After 1 or 4 hours 
of incubation with fluorescent-labeled mApoE-PA-LIPs, 
neuronal cultures were washed once and medium was 
substituted with the extracellular solution used for elec-
trophysiological recordings. Images were acquired with 
the LSM710 inverted confocal laser scanning microscope 
equipped with a Plan-Neofluar 63×1.4 oil objective (Carl 
Zeiss Meditec AG). λ=488 nm and bright field were used to 
detect LIPs and cells, respectively. The quantitative analysis 
of the green signal (mApoE-PA-LIPs) was performed using 
ImageJ software (ImageJ, U. S. National Institutes of Health, 
Bethesda, MD, USA).
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electrophysiological recordings
Recordings on primary cortical neurons were done at 
room temperature (22°C–25°C) applying the patch-clamp 
technique in the whole-cell configuration. The set-up was 
equipped with a Multiclamp 700B patch-clamp amplifier, 
a Digidata 1440A (both from Axon Instruments, Molecular 
Device, Sunnyvale, CA, USA), and pClamp 10.3 software 
(Molecular Devices LLC, Sunnyvale, CA, USA).
The cell capacitance and the resting membrane potential 
were measured immediately after obtaining the whole-cell 
configuration. The input resistance was calculated according 
to Ohm’s law.
After the measurement of the passive properties in voltage-
clamp mode, the amplifier was then switched to current-clamp 
mode, the bridge balance compensation was applied, and the 
membrane resting potential was held at −70 mV by inject-
ing the appropriate current. Neuronal firing was generated 
injecting 1 s-long depolarizing current pulses of increasing 
amplitude in 10 pA steps. The minimum current necessary to 
elicit an action potential (AP; the so-called rheobase current) 
and the frequency of APs were then measured.
The internal pipette solution contained the following (in 
mM): 120 K-gluconate, 15 KCl, 2 MgCl
2
, 0.2 EGTA, 20 
phosphocreatine-Tris, 2 ATP-Na
2
, 0.2 GTP-Na
2
, 0.1 leupep-
tin, and 10 K-HEPES, pH 7.2 with KOH. The bath solution 
contained the following (in mM): 129 NaCl, 1.25 NaH
2
PO
4
, 
1.8 MgSO
4
, 1.6 CaCl
2
, 3 KCl, 10 Na-HEPES, and 5 glucose, 
pH 7.4 with NaOH.16
Recordings were carried out after the exposure of the 
cell cultures for 1, 4, and 24 h to mApoE-PA-LIPs at 10 µM 
concentration or for 4 h with LIPs functionalized only with 
PA (PA-LIPs) or only with mApoE (mApoE-LIPs), at 10 µM 
concentration. To study the effect of the presence of Aβ in 
the culture, cells were exposed to Aβ 500 nM for 2, 4, or 
8 h. To evaluate the efficacy of the liposome treatment in 
presence of Aβ, we incubated the neurons with oligomers 
500 nM for 8 h, the last four of which were in coincubation 
with 10 µM of mApoE-PA-LIPs. To note, LIPs and Aβ were 
not applied during the recording phase of the experiments; 
thus, any change observed raised from the pretreatment 
performed before the cell culture dish was transferred to the 
electrophysiological recording setup.17
statistical analyses
Data are presented as mean ± SEM. Statistical analyses 
were conducted using OriginPro 8 software (OriginLab 
Corporation, Northampton, MA, USA). Group comparisons 
were made with unpaired Student’s t-test. An ANOVA was 
performed for multiple comparison, followed by Fisher cor-
rection. p-Values of 0.05 were considered significant (*).
Results
characterization of mapoe-Pa-lIP
In the present study, we utilized the previously described 
mApoE-PA-LIPs and PA-LIPs as a control. Size, polydis-
persity, and ζ-potential values are reported in Figure 1A. 
Figure 1 characterization of lIPs.
Notes: (A) size, polydispersity, and ζ-potential values of Pa-lIPs and mapoe-Pa-lIPs determined by dynamic light scattering and interferometic Doppler velocimetry. 
(B) Fluorescent spectra of Trp-mApoE peptide in solution (red line), after incubation with LIPs (dark line) or after mApoE-PA-LIPs purification (dark dotted line). 
(C) Fluorescent spectra of BODIPY-Fl c12-sphingomyelin embedded in lIPs before (−) and after purification (•••).
Abbreviations: lIPs, liposomes; Pa, phosphatidic acid.
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LIPs had a size below 200 nm diameter, low  polydisper-
sity index (PDI), and a negative ζ-potential indicating that 
dispersion was homogeneous in terms of dimension and 
was electrically stabilized. The yield of LIP surface func-
tionalization with mApoE peptide, followed by measuring 
the blue shift of Trp present in the peptide sequence, was 
65%±12% (Figure 1B), and the recovery of BODIPY-FL 
C12-Sm after LIP purification was 88.4%±9% (Figure 1C) 
vs a total lipid recovery 90%.
Biocompatibility and internalization
Primary cultures of neural cells from neonatal rats were 
exposed to mApoE-PA-LIPs for 4 or 48 h at a concentra-
tion of 10 µM (untreated cells as control). When comparing 
LIPs-treated and untreated cells, LDH assay displayed a 
maximum of 1% of plasma membrane distress and MTT 
assay a 7% of decrease in the metabolic activity (Table 1). 
These results indicated non-significant changes in plasma 
membrane integrity and metabolic stress, respectively, thus 
a high degree of biocompatibility.
NPs internalization is a common phenomenon in in vitro 
experiments; thus, confocal laser scanning microscopy was 
used to observe whether fluorescent mApoE-PA-LIPs were 
internalized by neural cells. The images acquired after 1 h 
of incubation revealed no particles inside the cytoplasm of 
neither neurons (specifically labeled with anti-βIII tubulin 
antibody; Figure 2A upper panel) nor astrocytes (labeled with 
GFAP antibody, Figure 2B upper panel). As the incubation 
time was extended up to 4 and 24 h, the status of LIPs aggre-
gation increased, and, again, the fluorescence was localized in 
the proximity of the cell plasmamembrane and not inside the 
cells (Figure 2A and B, lower panels). These qualitative data 
strongly suggested that neural cells did not uptake mApoE-
PA-LIPs independently from the duration of their exposure.
mapoe-Pa-lIPs incubation increased 
neuron excitability
Since mApoE-PA-LIPs are specific NPs designed to over-
come the BBB, all experiments presented from now on were 
conducted in order to evaluate the effects of the incubation 
of neurons with these given LIPs for different time intervals 
(1, 4, and 24 h). mApo-LIPs and PA-LIPs incubation was 
evaluated as a further control only when significant differ-
ences were observed in comparison to untreated cells.
Using the patch-clamp technique, we measured the 
passive membrane properties of neurons, such as cellular 
capacitance and input resistance, the resting membrane 
Figure 2 confocal images of primary cultures of neuronal cells incubated with mapoe-Pa-lIPs at different incubation time.
Notes: (A) anti-βIII tubulin antibody specifically marks neuronal cells, while (B) GFAP antibody specifically marks glial cells. Neural cultures were either non-treated or 
incubated with fluorescent mApoE-PA-LIPs for 1, 4, and 24 h. Images revealed that liposomes were not internalized by neurons (A) nor by glial cells (B).
Abbreviations: PA, phosphatidic acid; LIPs, liposomes; GFAP, glial fibrillary acidic protein.
? ?
???????????
??? ????
??? ???????????
??? ????
????????
Table 1 Biocompatibility of Pa-lIPs and mapoe-Pa-lIPs
LIPs Exposure 
time (h)
LDH release  
(%)
Reduction in MTT 
cleavage (%)
Untreated 4 0±3.5 0±1.12
mapoe-Pa-lIPs 4 0.5±2.1 (p=0.5) 3.2±1.3 (p=0.2)
Untreated 48 0±1.5 0±1.4
mapoe-Pa-lIPs 48 0.14±1 (p=0.6) 4±0.5 (p=0.3)
Notes: The release of lDh represents a sign of membrane damage, while the reduction 
in the cleavage of MTT to obtain formazan is an index of a decrease in the metabolic 
activity. results (presented as mean ± se) are representative for three independent 
experiments (n=4 for each experiment); p-value is calculated vs non-treated cells.
Abbreviations: Pa, phosphatidic acid; lIPs, liposomes; lDh, lactate dehydrogenase.
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potential, the rheobase current for AP generation, and the 
firing frequencies against the amplitude of injected current.
Following the treatment with mApoE-PA-LIPs, cell 
capacitance and cell resting membrane potential did not 
change; however, the input resistance significantly increased 
by 17% in neurons incubated for 4 h with mApoE-PA-LIPs, 
even though an increasing trend was also present when the 
incubation lasted for just 1 h. Cells exposed for the same 
period with PA-LIPs did not show any change, while a 13% 
increase was observed in cells incubated with mApoE-LIPs. 
All these data are summarized in Table 2.
The minimum current necessary to elicit an AP averaged 
at 25.9±2 pA in untreated cells. In neurons treated with 
mApoE-PA-LIPs, this parameter was overall smaller; in par-
ticular, after 4 h of incubation, two cellular populations were 
clearly distinguishable: in about half of the cells (51%, 26 
cells out of 51), the rheobase current averaged at 30.4±4 pA, 
while in the remaining fraction (49%, 25 cells out of 51), 
the rheobase current averaged at 20.4±2 pA ( p0.01). A 
very similar distribution was observed for the mApoE-LIPs 
incubated neurons (27.5±5 pA, n=40 and 18.06±4 pA, n=31, 
p0.01). In the other conditions tested, all the cells started 
to fire when the injected current amplitude was similar to the 
one of the untreated cells (25.4±4, 33.3±4, and 28.6±5 for 
cells incubated with mApoE-PA-LIPs for 1 or 24 h and with 
PA-LIPs for 4 h, respectively; Table 2). Figure 3A shows rep-
resentative trains of APs recorded in neurons either untreated 
(top) or treated with mApoE-PA-LIPs (center and bottom). 
Again, the analysis of the firing frequency revealed the coex-
istence of two different behaviors in neurons incubated for 
1 or 4 h with mApoE-PA-LIPs almost at all the amplitude 
of current steps injected (Figure 3B). In particular, 43 and 
58% of cells incubated for 1 and 4 h, respectively, exhibited a 
significantly higher (almost twofold) firing frequency, while 
in the remaining cells analyzed, the firing rate was similar to 
the one of untreated neurons (Figure 3C for the scattered data 
at 4 h of incubation). When the incubation was prolonged 
up to 24 h, the measured firing rate was no longer affected 
by the treatment.
As an example, at 60 pA of injected current, the untreated 
cells showed a frequency of firing of 15.9±1.4 Hz (n=60); in 
the population of neurons incubated with mApoE-PA-LIPs 
for 1 h, nine out of 16 cells (56.3%) fired at 17.1±2.4 Hz, 
while the remaining seven cells (43.7%) fired at 28.9±1.3 Hz 
( p0.01). After 4 h of incubation with mApoE-PA-LIPs, 
42% of cells (n=16) exhibited a frequency of 13.3±1.2 Hz and 
the remaining 58% (n=22) fired twice as frequently, reaching 
25.3±1.5 Hz ( p0.01, Figure 3C). In neurons treated for 
4 h with mApoE-LIPs we observed a similar behavior, with 
46% of cells (26 out of 57) firing at 13.7±1.4 Hz and 54% 
(31 cells) firing at 23.7±0.5 Hz ( p0.01). In PA-LIPs, the 
firing frequency was 16.3±2.2 Hz in 100% of cells (n=15).
To unravel the reason behind the coexistence of popula-
tions of cells firing at different frequencies, we observed 
the distribution of the fluorescent nanoliposomes on the 
neural cells cultures under similar conditions of those used 
for patch-clamp experiments. The differences in these live 
imaging pictures compared with the ones obtained with 
the immunofluorescence protocol (Figure 2) are related to 
the fact that the former samples were treated with a much 
more delicate approach, as described in the “Materials and 
methods” section, that did not include several strong washes. 
Figure 4A shows that while some cells were indeed in contact 
with mApoE-PA-LIPs (green arrows), some were not (white 
arrows). As well, the fluorescent spots (ie, mApoE-PA-LIPs) 
over the culture layer significantly increased their dimension 
with time, being 214±63, 403±153, and 1,125±488 nm at 1, 
4, or 24 h of incubation, respectively (Figure 4B). Moreover, 
the amount of cells having mApoE-PA-LIPs adherent to their 
surface was higher after 1 or 4 h of incubation and decrease 
Table 2 Passive membrane properties and other parameters measured in untreated neurons or in neurons incubated with lIPs
Untreated 
(n=73)
mApoE-PA-LIPs 
(1 h) (n=17)
mApoE-PA-LIPs 
(4 h) (n=51)
mApoE-PA-LIPs 
(24 h) (n=9)
PA-LIPs  
(4 h) (n=15)
mApoE-LIPs  
(4 h) (n=71)
cell capacitance (pF) 24.89±2 27.89±2 27.18±2 29.95±3 30.67±4 24.40±2
resting potential (mV) −45.25±2 −47.67±4 −45.46±2 −45.01±2 −50.20±3 −49.51±3
Input resistance (MΩ) 704±58 821.71±103 822±102 (p=0.04) 661.79±108 638.72±77 795±126 (p=0.04)
rheobase current (pa) 25.9±2 25.4±4 30.4±4 (n=25)
20.4±2 (n=26) 
(p0.01)
33.3±4 28.6±5 27.5±5 (n=40)
18.06±4 (n=31) 
(p0.01)
Notes: Data are presented as mean ± seM and are representative of at least three independent experiments. In the inset, an image of a typical neuron under patch-clamp 
experiment.
Abbreviations: lIPs, liposomes; Pa, phosphatidic acid; seM, standard error of the mean.
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at 24 h; in fact, the number of fluorescent events counted per 
field with time was 9.78±1.01, 8.2±0.46 and 5.8±0.5 at 1, 4 or 
24 h of incubation, respectively (Figure 4C). Unfortunately, 
for technical reasons, we could not perform patch-clamp 
experiments using fluorescent mApoE-PA-LIPs.
effects of aβ oligomers incubation or 
aβ oligomers and mapoe-Pa-lIPs 
co-incubation on neuron properties
In order to study the properties of neurons in presence of 
amyloid beta, we incubated the neural cultures with 500 nM 
of Aβ oligomers for 2, 4, and 8 h. The treatment had no effect 
on the neuronal resting membrane potential (−43.85±4 mV, 
2 h, n=5; −42.21±8 mV, 4 h, n=18; and −46.2±5 mV, 8 h, 
n=15), on the cell input resistance (996±32 MΩ, 2 h, n=4; 
806±167 MΩ, 4 h, n=15; and 834±164 MΩ, 8 h, n=13), on 
the rheobase current (27.3±3 pA, 2 h, n=4; 29.5±10 pA, 4 h, 
n=19; and 23.6±7 pA, 8 h, n=14), and on the frequency of 
firing (16.6±4 Hz, 2 h, n=3; 15.5±5 Hz, 4 h, n=6; and 12.5±4, 
8 h, n=8) (Figure 5A–D). At last, in order to test the efficacy 
of mApoE-PA-LIP on neuronal excitability in presence of 
Aβ in the culture, after 4 h of incubation with the oligomers, 
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Figure 3 Effect of mApoE-PA-LIPs on the firing frequency of neurons.
Notes: (A) representative current-clamp recordings from neurons; aPs were recorded during the application of 1 s of depolarizing injected current of 60 pa from a holding 
potential of −70 mV. The upper traces were recorded from untreated cells, the middle and the bottom traces were recorded from cells incubated with mapoe-lIPs for 4 h. 
The difference in the frequency of firing is evident. (B) Relationship between the average frequency of AP firing elicited and the respective amplitude of injected stimulus 
over the whole range of stimuli tested. Neurons incubated with mapoe-Pa-lIPs for 1 h (n=17) or 4 h (n=38) displayed sub-population of cells that fired with a significantly 
higher frequency (filled circles and squares, respectively) compared to control condition (n=60; empty star) or to longer time incubations (n=10; empty triangles) (*,#p0.01). 
For the sake of clarity of the plot, data related to the mapoe-lIPs incubation are not presented in this panel. (C) scattered plot showing the existence of two populations 
of firing frequency in neurons incubated for 4 h with mApoE-PA-LIPs or mApoE-LIPs when the injected current was 60 pA. Untreated neurons and neurons incubated with 
Pa-lIPs behaved similarly among themselves.
Abbreviations: Pa, phosphatidic acid; lIPs, liposomes; aP, action potential.
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mApoE-PA-LIPs were added for 4 h (ie, 4 h of incubation 
of Aβ alone plus 4 h of coincubation of Aβ and mApoE-
PA-LIPs). Under this condition, the cell resting membrane 
potential, the input resistance, and the rheobase current 
measured did not change significantly (−49.3±3 mV [n=9], 
902±141 MΩ [n=8] and 18.7±4 pA [n=8], respectively). 
Interestingly, though, concerning the frequency of firing, 
we could still point out the presence of two populations of 
neurons: one firing at 15±1 Hz (n=4) and another composed 
by two cells at 23.3 and 26.7 Hz, respectively (Figure 5D).
Discussion
The main obstacles to the development of potential thera-
peutic approaches for neurodegenerative diseases are the 
anatomical and physiological organization of the BBB, which 
is a weir of endothelial cells surrounding the capillaries of the 
CNS, preventing the passage of almost all pharmaceuticals 
and, thus, protecting the brain.
In the past few years, it has been proven that appropri-
ately functionalized NPs are able to cross the BBB, therefore 
representing a potential diagnostic and therapeutic tool of 
considerable impact in neurodegenerative disorders. In this 
context, a prominent place is certainly occupied by NPs 
developed for the treatment of AD, one of the most common 
causes of dementia in the world. AD is responsible for a pro-
gressive and irreversible loss of neuronal cells that, in turn, 
involves the manifestation and the sharpening of cognitive, 
behavioral, and physical deficits.
Several studies have previously suggested that mApoE-
PA-LIPs could potentially be advantageously used with 
regard to AD as they proved to reduce the Aβ burden in 
mouse animal models of the disease and to prevent memory 
impairment in a model of presymptomatic stage of AD.6,7 
This capability is likely attributable to the presence, on their 
surface, of PA molecules conferring the ability to bind Aβ 
with high affinity2 and of the peptide containing the receptor-
binding sequence of ApoE, improving their transport through 
the BBB.13
In the present study, we evaluated the effects of these 
double functionalized LIPs on primary cultures of cortical 
???
???
???
????
???
?
?
????? ?
?
?????
?????
??? ????
???
???
?????
????
???
???
???
???
?
?
?
?
?
??
?? ?
?
??? ??? ????
?????
??? ??? ?????
? ?
Figure 4 Fluorescence imaging on live cells.
Notes: (A) Distribution of the fluorescent mApoE-PA-LIPs on the neuronal cell cultures after 1 h (left), 4 h (central), or 24 h (right) of incubation. Green and white arrows, 
respectively, indicate cells interacting and non-interacting with mapoe-Pa-lIPs. (B) Box-chart showing the dimension of the green fluorescent spots corresponding to 
mApoE-PA-LIPs in the cell culture. The size increased over time (*significance versus the dimension at 1 h of incubation; p0.01). (C) Bar graph counting, on average, the 
fluorescent events found in each field analyzed.
Abbreviations: Pa, phosphatidic acid; lIPs, liposomes.
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neural cells isolated from neonatal rats with a particular 
attention to the neuron electrophysiological activity.
Previous results demonstrated the biocompatibility of 
mApoE-PA-LIPs on hCMEC/D3 cells,3 on HUVEC cells and 
on macrophages RAW264.7.18 Our data demonstrated that 
mApoE-PA-LIPs were biocompatible also with neural cells, as 
we did not detect signs of distress neither on the plasmamem-
brane (LDH release) nor on the metabolic activity (MTT 
production) for up to 48 h of incubation. This is an important 
result considering that mApoE-PA-LIPs role is likely to disag-
gregate and bind Aβ within the brain parenchyma.
Interestingly and differently to what has been previ-
ously observed in other cellular systems,3 these LIPs were 
not internalized in neurons nor in astrocytes. Low-density 
lipoprotein receptor (LDLR) and LDLR-related protein 1 
(LRP1) are the main metabolic receptors for lipoproteins in 
the brain, the first being mainly expressed in the astrocytes 
and the latter most expressed in neurons and in particular 
in cortical neurons of neonatal rats.19 Upon binding ApoE, 
LDLR and LRP1 form endocytotic vesicles to transport their 
ligands from the cell surface to intracellular compartments.20 
From our data, the internalization of the mApoE-PA-LIPs 
was prevented in neural cells. As already stated, LIPs used in 
this study exhibit the motif constituted by residues 141–150 of 
human apolipoprotein E. This motif possesses the conserved 
lysines and arginines crucial for the interaction between 
ApoE and LDLRs and subsequent nanoliposome internal-
ization in endothelial cells.3 Studies, not related to NPs, 
showed that in fibroblasts, the minimal sequence of ApoE 
recognized by the receptor has to be bound to lipoprotein 
in order to allow the internalization of the complex ligand–
receptor,21 and in HepG2 cells, it has to be linked to a class 
A amphipathic peptide.22 Up to now, there is no information 
regarding the internalization of the complex ligand–receptor 
in neurons, when only the minimal sequence of ApoE is 
present for the binding. Indeed the VLDL receptor does not 
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Figure 5 effects of aβ oligomers or aβ oligomers and mapoe-Pa-lIPs coincubation on neuron properties.
Notes: Panels represent the resting membrane potential (A), the cell input resistance (B), the rheobase current (C), and the firing frequency (D) in untreated neurons and 
in neurons incubated with aβ oligomers for 2, 4, or 8 h (data connected with the straight line). The empty symbols represent the same parameters measured after 4 h of 
aβ incubation alone followed by 4 h of coincubation with aβ plus mapoe-Pa-lIPs. (D) The empty circles are reported as averaged value of four out of six cells firing as the 
untreated ones, while the two empty circles in the dashed profile represent the subpopulation of neurons (two out of six) firing at a significantly higher frequency (*p0.01).
Abbreviations: aβ, β-amyloid peptide; Pa, phosphatidic acid; lIPs, liposomes.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
15
9.
14
9.
19
2.
11
8 
on
 2
8-
M
ay
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine 2018:13submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
4068
Binda et al
require the association of ApoE with lipids for recognition 
and binding, whereas the LRPR prefers lipid-bound forms 
of ApoE.23 In order to unravel the reason why LIPs are not 
internalized by neurons, one may incubate these cells with a 
series of synthetic sequences of ApoE of different length to 
study if there are specific requirements in the apolipoprotein 
E sequence for the internalization in this system. Yet, this is 
far beyond the goal of this paper.
The study of the electrical properties of the cells after 
mApoE-PA-LIPs incubation showed no changes in neuronal 
cell capacitance, but a significant increase in their input 
resistance. Considering that mApoE-PA-LIPs are primarily 
composed of lipids, that in electrical terms represent elements 
increasing the membrane electrical isolation, we can hypoth-
esize that if LIPs were not fused with the cell membrane 
(as Figures 2 and 5 suggest), they only adhered or promoted 
a minor plasmalemmal lipids incorporation, thus justifying 
the lack of the effects on the capacitance of the cell. This may 
however bring to either a redistribution of charge along the 
surface of the membrane of the excitable cells and thus the 
resistance may be altered24,25 or a direct effect of the lipids on 
the ion channels gating. In fact, while neutral lipids (ie, phos-
phatidylethanolamine, phosphatidylcholine) have little effect 
on channel activity, lipids with highly negatively charged 
head groups (ie, PA) strongly modulate ion channels.26 Data 
obtained incubating neurons with mApoE-PA-LIPs were 
comparable with those obtained with mApoE-LIPs (thus 
without PA and its negatively charged head groups) leaning 
toward the first hypothesis. Moreover, we hypothesize that 
the reason why cells exposed to PA-LIPs did not show any 
change in input resistance compared to mApoE-PA-LIPs is 
related to the fact that without mApoE, the liposome may 
not stick to the cell membrane.
The value of the resting membrane potential was not 
different after incubation of neurons with mApoE-PA-LIPs, 
while the rheobase current decreased significantly, coher-
ently with the increase in the input resistance. The same 
results were obtained when the incubation was done with 
mApoE-LIPs.
In terms of firing frequency, in neurons incubated with 
mApoE-PA-LIPs (as well as with mApoE-LIPs) for a period 
up to 4 h, we could identify two different populations: one 
population that fired like the untreated cells and a second 
population that fired at twice that frequency. Longer incu-
bation periods resulted in the disappearance of this latter 
population of cells. Taking advantage of the live fluorescence 
images, we can speculate that the mApoE-PA-LIPs dispersed 
in the culture medium had the (static) chance to interact with 
cultured neurons. But, over time, they aggregate as evidenced 
by the increase in the area of the single fluorescent spot. By 
aggregating, the number of objects available to interact with 
the cells decreased, as demonstrated by the number of fluo-
rescent events counted per field, making the interaction less 
probable, thus detectable. From the data shown, it seems that 
the ideal time to observe the interaction phenomenon and its 
consequences on neurons is between 1 and 4 h of incubation. 
At 24 h, the aggregation phenomenon seized the LIPs limit-
ing the number of the neuron-mApoE-PA-LIPs interaction 
events; and in fact, after 24 h of incubation with mApoE-PA-
LIPs, the effect on firing rate was not distinguishable from 
that of the untreated or PA-LIPs treated neurons.
Overall, the results obtained after the incubation of 
neurons with mApoE-PA-LIPs were very similar to the 
ones gathered after mApoE-LIPs incubation, suggesting 
that mApoE peptide is mainly responsible for the changes 
observed in the electrical properties of the cells.
Since AD implies the presence of Aβ oligomers and plaques 
in the brain, it would be interesting to have the possibility to 
investigate the efficacy of mApoE-PA-LIPs on the electrical 
properties of neurons isolated from an AD model. The litera-
ture reports few studies in which this topic was investigated 
in vivo,27 or in hippocampal slices, or in primary hippocampal 
neurons from neonatal mice.17,28 Results demonstrated a hyper-
activity in terms of calcium release27 and in the increase in the 
firing frequency of APs evoked in response to current steps28 
leaving many basic intrinsic neuronal properties unaltered.17,28 
Indeed, the isolation of cortical neurons from adult rats or mice 
is not easily feasible. In the literature, there is only one paper 
aiming at developing a method for preparing isolated cells 
of medial vestibular nucleus (MVN) from adult mice, which 
however remain viable only for 3 days in culture.29 These 
cells, however, are not consistent with our model. Moreover, 
in order to study the electrical properties of isolated neurons, 
embryonic or neonatal animals are preferred for culturing. 
For these reasons, we mimicked the AD model, treating the 
primary neural cultures with Aβ oligomers17 for increasing 
time of incubation. Consistent with previous results,17,28 also in 
our study, Aβ did not induce changes in the passive properties 
of neurons, and also the firing frequency remained stable, 
as reported previously.17 The reason why we did not detect 
hyperactivity in neurons incubated with Aβ may simply rely 
in the fact that we recorded APs in single cells and not in brain 
slices. Moreover, the strategy we used for the incubation is 
a balance between a reasonable time to allow Aβ to produce 
its effects and the inevitable decline that it produces with the 
inevitable decline on cell viability that it produces with time, 
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which may not allow patch-clamp experiments to be performed 
at all. It is worthy of note, however, that after the incubation 
with Aβ alone followed by 4 h of co-incubation of Aβ plus 
mApoE-PA-LIPs, we could still detect a fraction (2 cells out 
of 6) of the neurons firing at higher frequency compared to the 
neurons incubated for 8 h only with Aβ, suggesting that the 
efficacy of mApoE-PA-LIPs is maintained even in presence 
of the oligomers.
Conclusion
The most relevant results concerning the effect of the incu-
bation of neurons with mApoE-PA-LIPs were the transient 
increase in the input resistance and the decrease of the 
rheobase current, consistent with an ultimately transient 
increase in neuronal excitability. In particular, a higher input 
resistance means that less synaptic input (or current injection) 
is necessary to lead to larger voltage changes, as the decrease 
in the rheobase current confirmed. Thus, changes in input 
resistance can change the responsiveness of the neurons to 
other inputs. This adjustment in intrinsic excitability is usu-
ally at the basis of plasticity of the response of the membrane 
of excitable neurons acting as a metaplasticity mechanism 
by lowering the threshold for synaptic changes.30
Metaplasticity develops as a result of a series of time-
dependent events: an initial priming event (eg, LIPs adhesion) 
induces physiological or biochemical changes in neurons 
that can modulate plasticity induced by a subsequent event 
(eg, electrical stimulation); these changes may have an 
impact, for example, in the enhanced ability of an excitatory 
postsynaptic potential (EPSP) to generate an AP, again, as 
proved by the decrease in the rheobase current found.31
Modulation of intrinsic excitability may act as an adjust-
able gain control mechanism and have consequences for the 
integration processes.
Aging-related deficits in learning have been linked to 
failure to modulate intrinsic excitability, in the sense that a 
reduced intrinsic excitability may be an important predic-
tor of cognitive decline; with this in mind, we may argue 
that an increase in intrinsic excitability, as we found after 
the incubation of neurons with mApoE-PA-LIPs, may be a 
predictor of cognitive preservation.
However, since the changes in intrinsic plasticity were 
transient, we cannot say that they code for the memory itself, 
but this transient enhancement of excitability may promote 
processes that allow successful memory formation and that 
facilitate acquisition of new learning.
It is well known that alterations in intrinsic properties of 
neuronal membranes are regarded as an important mechanism 
involved in the abnormal excitability of cortical circuitry 
and possibly account for the susceptibility to initiation and 
spread of seizures.30,32,33 Nevertheless, in a previous study 
where mice were treated with mAPO-PA-LIPs for 7 months 
and observed for 3 more months,7 no seizure-related behav-
iors such as immobility, compulsive spitting, alteration in 
locomotor activity, social relationships, and reactivity to 
environmental stimuli34 were observed.
LIPs and, in particular, mApoE-PA-LIPs have great 
potential in biotechnology and medicine, in particular in 
the treatment of AD. Some of the initial concerns regarding 
their possible toxicity have been widely alleviated by the 
demonstration of their biocompatibility in several cellular 
models as well as in primary neural cultures. Their ability 
to reduce Aβ accumulation in the brain6 brought us to inves-
tigate their effect on electrical properties of neurons, given 
their proximity when passing the BBB. Data presented here, 
besides adding some relevant information on the lack of LIPs 
internalization by neuronal cells, indicate that treatment with 
mApoE-PA-LIPs transiently increases neuronal excitability 
and suggests the basis for the interpretation of the cogni-
tive recovery found in previous work.7 The modulation of 
the intrinsic excitability could be an important factor in the 
search for neurobiological approaches to mitigate or prevent 
the onset of aging-related cognitive impairments and even 
rescue those deficits after they emerge.
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